Rational therapy of acute viral rhinosinusitis in outpatient practice
https://doi.org/10.51793/OS.2024.27.3.012
Abstract
Background. Acute respiratory viral infections are the most common reason for seeking care from outpatient physicians. Most cases of acute respiratory viral infections are caused by different serotypes of respiratory viruses, which cause diseases with very similar clinical symptoms. Acute rhinosinusitis holds one of the leading positions in the clinical picture of acute respiratory viral infections. Approaches to the therapy of this disease include the influence on various links of the pathological process. Preference is given to drugs that have a wide range of therapeutic effects with minimal or no side effects. Plant medicines that have a complex secretolytic, secretomotor, mucoactive, anti-inflammatory, antiviral, antibacterial and antiseptic action may become the drugs of choice in the treatment of patients with acute viral rhinosinusitis. Medicines of plant origin have a number of undoubted advantages, such as the breadth of therapeutic effect, compatibility with other drugs and among themselves, the possibility of safe and prolonged use in uncomplicated forms of disease, use to improve the effectiveness of specific treatment and supportive therapy, the possibility of use at home. All this makes them one of the essential components of treatment of patients in outpatient and polyclinic practice, especially since modern herbal medicines, having a pronounced effect on cold symptoms, do not show significant side effects.
Conclusion. Convincing evidence-based data on the efficacy and safety of herbal preparations allow to prescribe them both as monotherapy and as part of the complex treatment of diseases of the nose and sinuses to reduce the severity and duration of symptoms of acute viral rhinosinusitis, as well as to prevent the development of complications.
About the Author
A. A. StremoukhovРоссия
Anatoly A. Stremoukhov, Dr. of Sci. (Med.), Professor, Director of the Institute of Professional Education
125ZH, bldg. 6 Varshavskoe shosse, Moscow, 117587
References
1. Acute sinusitis. Clinical Guidelines, 2021.
2. Acute rhinosinusitis. Recommendations of the Russian Society of Rhinologists, 2021.
3. Lazarevich I. L, Kozlov V. S. Acute rhinosinusitis: diagnostics and treatment. Vestnik Oto-Rino-Laringologii. 2013; 78 (5): 88-92. (In Russ.)
4. Shilenkova V. V, Shilenkov K. A. EPOS-2020. What’s new? Russian Rhinology. 2020; 28 (2): 94-100. (In Russ.)
5. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; Supplement 29: 1-464.
6. Bittner Claudia B. et al. Efficacy and effectiveness of the herbal medicinal product BNO 1016 in the management of acute rhinosinusitis in the context of antibiotic stewardship. Postgraduate Medicine. 2023, 135: 6, 607-614.
7. Package insert – information for the patient. Sinupret® extract, coated tablets.
8. Glatthaar-Saalmüller B., Rauchhaus U., Rode S., et al. Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections. Phytomedicine, 2011; 19 (1): 1-7.
9. Ismail C. Pharmacology of Sinupret. Recent results on the rational for the Sinupret compound. HNO. 2005; 53 (Suppl 1): S38-42.
10. Jund R., Mondigler M., Stammer H., Stierna P., Bachert C. Herbal medicinal product Sinupret extract (BNO 1016) is safe and effective in the treatment of acute viral rhinosinusitis. Consilium Medicum. 2022; 24 (3): 186-192. DOI: 10.26442/20751753.2022.3.201314
11. David Martin, Marcel Konrad, Charles Christian Adarkwah & Karel Kostev (2020): Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals – a retrospective cohort study. Postgraduate Medicine. DOI: 10.1080/00325481.2020.1751497.
Review
For citations:
Stremoukhov A.A. Rational therapy of acute viral rhinosinusitis in outpatient practice. Lechaschi Vrach. 2024;(3):71-75. (In Russ.) https://doi.org/10.51793/OS.2024.27.3.012
JATS XML



















